Literature DB >> 25716688

[Diagnosis of overactive bladder (OAB)].

M Kurosch1, R Mager, K Gust, M Brandt, H Borgmann, A Haferkamp.   

Abstract

Overactive bladder (OAB) is a symptom complex which is present in approximately 17% of the European population. It is observed in the presence or absence of incontinence (wet or dry) and is associated with a high degree of psychological stress as well as high costs for the healthcare system. Myogenic, urothelial and neurogenic factors lead to frequently unknown changes of muscular, neural and connective tissue. The diagnosis of OAB is empirical and can be used as a basis for initial treatment, while lower urinary tract symptoms have to be evaluated up front. As there are no established biomarkers for OAB, a definitive diagnosis is problematic. It is important to carry out routine diagnostics including a detailed medical history and if needed urodynamic evaluation of the patient. Therapy of OAB will be the topic of a further continuing medical education (CME) article entitled "Therapy of overactive bladder (OAB)".

Entities:  

Mesh:

Year:  2015        PMID: 25716688     DOI: 10.1007/s00120-014-3718-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  28 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Authors:  Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Authors:  P Van Kerrebroeck; K Kreder; U Jonas; N Zinner; A Wein
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

4.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

Review 5.  A neurologic basis for the overactive bladder.

Authors:  W C de Groat
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

6.  Validation of the overactive bladder symptom score.

Authors:  Jerry G Blaivas; Georgia Panagopoulos; Jeffrey P Weiss; Chandra Somaroo
Journal:  J Urol       Date:  2007-06-14       Impact factor: 7.450

7.  Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.

Authors:  K Coyne; D Revicki; T Hunt; R Corey; W Stewart; J Bentkover; H Kurth; P Abrams
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

8.  Effects of denervation on muscarinic receptors in the rat bladder.

Authors:  K T Gunasena; A J Nimmo; J F Morrison; E M Whitaker
Journal:  Br J Urol       Date:  1995-09

9.  EAU guidelines on assessment and nonsurgical management of urinary incontinence.

Authors:  Malcolm G Lucas; Ruud J L Bosch; Fiona C Burkhard; Francisco Cruz; Thomas B Madden; Arjun K Nambiar; Andreas Neisius; Dirk J M K de Ridder; Andrea Tubaro; William H Turner; Robert S Pickard
Journal:  Eur Urol       Date:  2012-08-31       Impact factor: 20.096

10.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

View more
  1 in total

1.  [Urodynamic classification of male patients with symptoms of overactive bladder and the outcome classification].

Authors:  T Wang; K X Xu; W Y Zhang; H Hu; X W Zhang; H R Wang; X H Liu; J W Chen; X P Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.